FTO rs1421085: Understanding the Obesity-Associated Variant
The rs1421085 variant is a well-studied single nucleotide polymorphism located within the FTO gene. It is widely recognized in genetic research for its statistical association with increased body mass index (BMI) and obesity risk across various populations.
What each genotype means
Lower obesity risk
This genotype is associated with a lower risk of increased body mass index compared to those carrying the C allele. Research suggests this version of the variant does not disrupt the ARID5B repressor motif, allowing for normal regulation of thermogenesis-related genes like IRX3 and IRX5.
This is the non-risk genotype, which is common in many global populations.
Increased obesity risk
Carrying one copy of the C allele is associated with a higher statistical risk of increased body mass index. This variant may disrupt regulatory mechanisms in adipocytes, potentially leading to reduced mitochondrial thermogenesis and a shift toward fat storage.
This heterozygous genotype is frequently observed in diverse populations worldwide.
Higher obesity risk
This genotype is associated with the highest statistical risk for increased body mass index among the three possibilities. The C allele is thought to disrupt an ARID5B repressor motif, which can impair the browning of fat cells and decrease energy expenditure through thermogenesis. Please discuss any concerns regarding weight management or metabolic health with your clinician.
This homozygous risk genotype is common, though its prevalence varies significantly across different ancestral groups.
What is rs1421085?
The rs1421085 variant is a specific change in the DNA sequence located within the FTO (fat mass and obesity-associated) gene on chromosome 16. In genetic terms, it is a single nucleotide polymorphism, or SNP, where a single building block of DNA—a nucleotide—differs between individuals. Specifically, this variant involves a substitution where a thymine (T) can be replaced by a cytosine (C). Because this SNP sits in a non-coding region of the gene, it does not change the protein structure directly. Instead, researchers believe it acts as a regulatory element, influencing how the FTO gene is expressed in different tissues, such as the hypothalamus and adipose tissue. By altering these regulatory signals, the variant may influence biological pathways related to energy balance and fat storage.
The Role of the FTO Gene
The FTO gene is primarily known for its role in regulating energy homeostasis and body weight. Research indicates that the gene is expressed in the hypothalamus, a region of the brain that serves as a master controller for appetite and energy expenditure. Additionally, FTO is found in adipose tissue, where it may play a role in the development of fat cells and thermogenesis—the process by which the body generates heat. While the exact molecular mechanisms are still being investigated, studies suggest that FTO variants like rs1421085 may disrupt the normal regulation of nearby genes, such as IRX3 and IRX5, which are involved in adipocyte browning and energy metabolism. This disruption is thought to contribute to the observed differences in body mass and fat distribution among individuals carrying different versions of the variant.
Evidence and Associations
The association between rs1421085 and obesity-related traits is supported by a substantial body of evidence from genome-wide association studies (GWAS). Researchers have consistently observed that individuals carrying the risk allele show a higher average BMI and an increased predisposition to obesity compared to those who do not. While the statistical association is robust and replicated across many diverse populations, it is important to note that the effect size of any single variant is typically modest. Genetics is only one piece of a complex puzzle that includes diet, physical activity, and environmental factors. The evidence strength for this association is considered moderate, as it highlights a clear genetic contribution to weight-related traits without implying that the variant is the sole cause of obesity in any individual.
Population Frequency and Variability
The rs1421085 variant is considered a common SNP, meaning it is found at significant frequencies across many human populations. However, the specific frequency of the risk allele can vary considerably depending on ancestral background. For instance, some studies have noted differences in allele frequencies between European, Asian, and other populations, which can influence the prevalence of the associated traits within those groups. Because the variant is common, a large portion of the general population carries at least one copy of the risk allele. Researchers often use this high frequency to study the variant's impact on a population level, though they caution that findings in one ethnic group may not always translate perfectly to another due to differences in genetic background and environmental interactions.
Interpreting Your Genetic Information
Understanding your genotype for rs1421085 provides insight into your genetic predisposition, but it is not a diagnostic tool. Because obesity is a multifactorial condition, having a specific genotype does not guarantee a particular health outcome, nor does it mean that weight management is impossible. Genetic information should be viewed as a piece of data that can help you understand your body's tendencies, not as a fixed destiny. If you are concerned about your weight or metabolic health, the most effective approach is to consult with a healthcare professional or a registered dietitian. They can help you interpret your health status in the context of your entire lifestyle, medical history, and environment, rather than focusing on a single genetic marker.
How common is this variant?
The rs1421085 variant is a common polymorphism found across diverse global populations, though the frequency of the risk allele varies by ancestry.
Frequently asked questions
Does having the FTO risk allele mean I will be obese?
No, having the risk allele does not mean you will be obese. It is a statistical association, meaning it may slightly increase your predisposition, but lifestyle factors like diet and exercise play a much larger role in determining body weight.
Can I change my FTO gene expression?
You cannot change your DNA sequence. However, research suggests that healthy lifestyle choices, such as regular physical activity and a balanced diet, can help manage weight regardless of your genetic predisposition.
Is rs1421085 the only gene related to weight?
No, body weight is a complex trait influenced by hundreds of different genetic variants, as well as environmental and behavioral factors. FTO is simply one of the most well-studied genes in this area.
Should I get tested for this variant?
Genetic testing for common variants like rs1421085 is generally not recommended for clinical decision-making regarding weight loss. It is more useful to focus on evidence-based lifestyle changes with the guidance of a healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1421085?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.